The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study. (2018)

First Author: Herrington WG


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 30524708

Publication URI:

Type: Journal Article/Review

Volume: 11

Parent Publication: Clinical kidney journal

Issue: 6

ISSN: 2048-8505